Analyst Price Targets — OPT
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 25, 2025 12:20 pm | Matthew Caufield | H.C. Wainwright | $2.00 | $3.41 | TheFly | Opthea downgraded to Neutral from Buy at H.C. Wainwright |
| December 8, 2022 6:19 am | — | H.C. Wainwright | $14.00 | $4.97 | Benzinga | HC Wainwright & Co. Initiates Coverage On Opthea with Buy Rating, Announces Price Target of $14 |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for OPT

Optima Health trading 'in line' as it continues to grow UK and Ireland platform
Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) said full-year revenue rose around 15% to approximately £121 million for the year ended 31 March 2026, in line with market expectations, as the occupational health and wellbeing services provider continued to grow its UK and Ireland platform. The AIM-listed group said adjusted EBITDA for FY26 is expected to be around 10% ahead of previous market expectations, as…
Proactive Investors • Jun 16, 2026
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OPT.
U.S. House Trading
No House trades found for OPT.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
